Expert review ends 2021 national talks drugs have been confirmed!

On September 28, the National Medical Insurance Administration issued new news: In accordance with the "2021 National Medical Insurance Drug Catalog Adjustment Work Plan", the National Medical Insurance Administration organized experts to conduct multiple rounds of review of the declared drugs that passed the formal review in the 2021 National Medical Insurance Drug Catalog adjustment.

.
At present, the expert review phase has ended

According to the announcement, all applicant companies can log on to the National Medical Insurance Public Service Platform (fuwu.
nhsa.
gov.
cn) "2021 National Medical Insurance Drug Catalog Adjustment Application Module" (hereinafter referred to as the "application module") to check the review results
.

If the result of the review is "new product to be negotiated", "new indication to be negotiated", "to renew the contract" and "to be renewed according to the simplified procedure", it means that the drug or indication will be included in the 2021 medical insurance drug Access to the scope of negotiation and obtaining the qualification for negotiation or contract renewal does not mean that the drug or indication has been included in the 2021 National Medical Insurance Drug List
.

The National Medical Insurance Bureau requires that the drugs included in the 2021 national medical insurance drug access negotiation scope, please download the confirmation letter, authorization letter and negotiation material template in the "application module" and fill in and submit as required
.
Please click on "Details" in the "Negotiation Information" column of the "Declaration Module" to view the contents of the negotiation reference drugs (including the treatment plan), the main specifications of the negotiation and the limited payment range determined by the expert review

At the same time, the National Medical Insurance Administration stated that, in order to ensure the smooth progress of the follow-up phase of the catalogue adjustment, before the official release of the National Medical Insurance Drug Catalogue in 2021, applicants are requested not to release any information about this catalogue adjustment

With reference to the previously announced adjustment schedule, it is expected that the negotiation will be officially entered in October, and the results will be announced in November at the latest